Published Date: 17 Feb 2023
UK: More health is associated with more cardiovascular disease (CVD) and higher triglycerides...
Read Full NewsFor men with intermediate-risk prostate cancer, SBRT may beat longer-course radiotherapy in some measures of quality of life, but not disease-free survival.
Weekly electronic symptom monitoring was associated with improved fatigue and physical functioning in a randomized trial of patients with metastatic breast cancer.
Outcomes improve when a novel, first-in-class immunomodulatory drug is combined with daratumumab and dexamethasone in previously treated patients.
1.
Children with the "Failure to Launch" Syndrome in Adulthood Have New Hope.
2.
Tipiracil hydrochloride and trifluridine tablets are approved by the USFDA for Natco Pharma.
3.
Headlines About Doc Who 'Catches' Patient's Cancer Are Popping Up Again
4.
Next-Generation KRAS G12C Inhibitor Shows 'Robust' Efficacy in Advanced Lung Cancer
5.
Liver cancer survival rates reflect income disparities
1.
Unraveling the Mysteries of Coagulopathy: A Comprehensive Definition
2.
Exploring the Use of Bevacizumab in Treating Different Types of Cancers
3.
Chemotherapy Advances: Albumin I.V., Trastuzumab, Liposomal Doxorubicin & More
4.
Innovative Approaches in Oncology for Modern Medicine
5.
Blastic Plasmacytoid Dendritic Cell Neoplasm and the Dawn of AI-powered Diagnostics
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part III
3.
Updates on Standard V/S High Risk Myeloma Treatment
4.
Best Practices in Hematology
5.
Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation